Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report

Abstract Background Immune checkpoint inhibitors are effective therapies for a wide range of malignancies. Their increased use has led to a wide range of immune-related adverse effects including skin, gastrointestinal, pulmonary, endocrine, cardiac, and neurologic complications. Case presentation We...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jason Cham, Daniel Ng, Laura Nicholson
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-05-01
Edice:	Journal of Medical Case Reports
Témata:	Checkpoint inhibitors Immunotherapy Adverse effects Myocarditis Myositis Myasthenia gravis
On-line přístup:	https://doi.org/10.1186/s13256-021-02858-7
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!